{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T20:09:26Z","timestamp":1775938166659,"version":"3.50.1"},"reference-count":27,"publisher":"American Physiological Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Gastrointestinal and Liver Physiology"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:p>Reduced sinusoidal endothelial nitric oxide (NO) production contributes to increased intrahepatic resistance and portal hypertension after liver injury. We hypothesized that V-PYRRO\/NO, an NO donor prodrug metabolized \u201cspecifically\u201d in the liver, would reduce portal venous pressure (PVP) without affecting the systemic vasculature. Liver injury was induced in male BALB\/c mice by weekly CCl<jats:sub>4<\/jats:sub>gavage. PVP and mean arterial pressure were recorded during intravenous administration of V-PYRRO\/NO. In vivo microscopy was used to monitor sinusoidal diameter and flow during drug administration. Mean PVP was increased in CCl<jats:sub>4<\/jats:sub>-treated mice compared with sham-treated mice. In dose-response experiments, the minimum dose of PYRRO\/NO required to acutely lower PVP by 20%, the amount believed to yield a clinically meaningful outcome, was 200 nmol\/kg. This dose decreased portal pressure in cirrhotic (23.4 \u00b1 2.0%, P &lt; 0.001 vs. vehicle) and sham-treated (19.5 \u00b1 2.3%, P &lt; 0.001 vs. vehicle) animals by a similar magnitude. This concentration also led to dilation of hepatic sinusoids and an increase in sinusoidal volumetric flow, consistent with a reduction of intrahepatic resistance. The effect of V-PYRRO\/NO on mean arterial pressure was significant at all concentrations tested, including the lowest, 30 nmol\/kg ( P &lt; 0.001 vs. vehicle for all doses). We conclude that V-PYRRO\/NO had widespread vascular effects and, as such, is unlikely to be suitable for treatment of portal hypertension. As the potential of this or other similar compounds for treatment of portal hypertension is evaluated, effects on the systemic vasculature will also need to be considered.<\/jats:p>","DOI":"10.1152\/ajpgi.00368.2007","type":"journal-article","created":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T01:43:49Z","timestamp":1206063829000},"page":"G1311-G1317","source":"Crossref","is-referenced-by-count":21,"title":["Effect of the nitric oxide donor V-PYRRO\/NO on portal pressure and sinusoidal dynamics in normal and cirrhotic mice"],"prefix":"10.1152","volume":"294","author":[{"given":"Claire","family":"Edwards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Qiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don C.","family":"Rockey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50133"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-200211000-00005"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007127"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1021\/bi972307p"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91740-3"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.151136298"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(00)00197-6"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Fulton D, Gratton JP, Sessa WC.Post-translational control of endothelial nitric oxide synthase: why isn't calcium\/calmodulin enough?J Pharmacol Exp Ther299: 818\u2013824, 2001.","DOI":"10.1016\/S0022-3565(24)29198-9"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.41.25437"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1124\/mol.65.1.130"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.3233\/BIR-1972-9402"},{"key":"R12","unstructured":"Kochanek KD, Smith BL.Death: preliminary data for 2002.Natl Vital Stat Rep52: 1\u201348, 2004."},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50063"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1038\/nm1289"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9419"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808203390807"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i41.6639"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200620"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200101270-00004"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70487-1"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Rodriguez-Vilarrupla A, Fernandez M, Bosch J, Garcia-Pagan JC.Current concepts on the pathophysiology of portal hypertension.Ann Hepatol6: 28\u201336, 2007.","DOI":"10.1016\/S1665-2681(19)31950-7"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1021\/jm9701031"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70408-7"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1080\/00498250110102665"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80228-1"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Vorobioff J, Bredfeldt JE, Groszmann RJ.Increased blood flow through the portal system in cirrhotic rats.Gastroenterology87: 1120\u20131126, 1984.","DOI":"10.1016\/S0016-5085(84)80072-4"},{"key":"R27","unstructured":"Zimmerhackl B, Parekh N, Brinkhus H, Steinhausen M.The use of fluorescent labeled erythrocytes for intravital investigation of flow and local hematocrit in glomerular capillaries in the rat.Int J Microcirc Clin Exp2: 119\u2013129, 1983."}],"container-title":["American Journal of Physiology-Gastrointestinal and Liver Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpgi.00368.2007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T05:39:03Z","timestamp":1738129143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpgi.00368.2007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1152\/ajpgi.00368.2007"],"URL":"https:\/\/doi.org\/10.1152\/ajpgi.00368.2007","relation":{},"ISSN":["0193-1857","1522-1547"],"issn-type":[{"value":"0193-1857","type":"print"},{"value":"1522-1547","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}